Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTyratech Regulatory News (TYR)

  • There is currently no data for TYR

Trading Update

22 Sep 2008 07:00

RNS Number : 9263D
TyraTech, Inc.
22 September 2008
 



For immediate release

22 September 2008

TYRATECH, INC.

("TyraTech" or "the Company")

Trading Update 

TyraTech, Inc. (AIM: TYR), a leading independent novel pesticide company for human, animal and environmental health, today announces an update on trading.

TyraTech's commercial programmes are progressing well. However, due to the lengthy nature of commercial discussions with partners and customers, as well as TyraTech's disciplined approach to partner selection and deal negotiation, the Board anticipates that revenues and profits for the full year 2008 are unlikely to meet with current market expectations. The Company does, however, expect to report on positive progress from sales and partnership discussions before year end.

Revenue generating products and near term cash flows 

TyraTech's lead insecticide product, Naturals™ Crawling Insect Killer, has enjoyed growth in distribution outlets in the US via own label sales and a local distribution partner, SYSCO.

TyraTech's WasteSolver business is progressing well as evidenced by the growing customer pipeline and receipt of four signed orders plus a further four signed letters of intent. While sales of this product have been initially slower than expected due to the extended sales lead time necessary for farmers to evaluate the new waste management solution, customer feedback and the current order book confirm management's confidence in this product line.

Partnerships and milestones

TyraTech has diversified revenue streams which combine strong relationships with blue-chip partners and direct sales. The Company is actively involved in several partnership discussions with new partners covering consumer products, agriculture and animal health, and has a signed letter of intent in place with one significant US business for one of these key markets. The Board of TyraTech expects positive commercial progress and newsflow in the near to medium term on these discussions. However, despite real progress, signatures and timing of new partnerships and product launches have proved difficult to predict. In addition, whilst TyraTech reports that existing partner development programmes are progressing well, related milestones are now not expected until H1 2009.

Financials

The Company will announce its interim results on 26 September 2008 where revenue for the first half of the year is anticipated to be approximately $2.4 million with an operating loss of $9.8 million. The cash balance at the end of June 2008 was $14.9 million which the Board expects to be sufficient for the Company's current operations. 

Based on recent progress in the pipeline, work with current and future partners and new scheduled product releases, TyraTech expects to report strong growth in 2009. The Company's revenues are also expected to continue growing throughout H2 2008.

Commenting on the announcement, Douglas Armstrong Ph.D., Chief Executive Officer of TyraTech, said: "TyraTech has a diversified business model with revenue potentially arising from a number of different sources. We continue to receive strong feedback from our customers, and have made progress across all markets. We are therefore confident we can deliver successfully on our current and new potential partnerships.

"While the business operations have progressed well, we have been disappointed at the speed of entry into certain markets. As a management team we remain positive that we can execute our business plan and strategy and that there is potential for high gross margins on products and up front and milestone payments from partnering and licensing deals. We trust to be able to evidence this progress through announcements for the rest of 2008 which will have a positive impact on 2009 revenues."

For further information please contact:

TyraTech Inc.

Keith Bigsby, Chief Financial Officer +1 (321) 409 7714

www.tyratech.com

Nomura Code Securities

Charles Walker +44 (0)20 7776 1200

www.nomuracode.com

Buchanan Communications

MaryߛJane Johnson / Lisa Baderoon / Catherine Breen +44 (0) 20 7466 5000

About TyraTech

TyraTech was formed in 2004 to develop and commercialise products for the control of invertebrate pests and pathogens using the Company’s proprietary technology. TyraTech, which already has a product on the market, is positioned for human health, animal health and pesticide market opportunities which total over $23 billion globally. TyraTech’s technology provides the Company with a wide variety of product and business opportunities in many markets and geographic regions. The differentiating feature of these products is the potential to have a combined level of potency and safety that other invertebrate control products are unable to offer. TyraTech’s platform brings many of the principles of drug discovery and development to the fields of insecticides and parasiticides. By targeting specific chemoreceptors that are found in invertebrates but not in humans and animals, TyraTech can produce products that use natural plant derived compounds targeting these receptors.

TyraTech's plan for the use of its technology is to develop selected proprietary active ingredients which can then be used across a wide variety of market segments, either by development partners or by TyraTech itself. TyraTech already has products or partnerships in the areas of professional and horticultural insect control, and for an insect/mosquito repellent. TyraTech also has an innovative partnership with Kraft to use its natural oils to develop functional foods for improving the health of the more than 2 billion people worldwide subject to intestinal parasitic infections.

TyraTech also has a separate technology with associated intellectual property that is the basis for the Sustainable Solutions business. This technology has been incorporated into specialised dairy farm equipment for processing cattle manure waste to a usable material for TyraTech to sell as a commercial plant growing medium. For more information please visit www.tyratech.com.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTPUUAPBUPRGRG
Date   Source Headline
8th Nov 20185:25 pmRNSTyratech
2nd Nov 20185:30 pmRNSTyratech
31st Oct 20183:01 pmRNSResult of Special Meeting, Cancellation from AIM
25th Oct 20187:00 amRNSSpecial Meeting and Acquisition Update
18th Oct 20183:00 pmRNSNominee accounts
9th Oct 20182:23 pmRNSPosting of Proxy Statement and Timetable Update
5th Oct 201810:05 amRNSUpdate
28th Sep 20188:50 amRNSInterim Results
28th Sep 20187:00 amRNSConditional Merger Agreement Signed with AMVAC
23rd May 20187:00 amRNSFinal Results
9th May 20187:00 amRNSProgress in 2018 on products and milestones
3rd May 20187:00 amRNSChange of Adviser
24th Jan 20185:44 pmRNSHolding(s) in Company
18th Jan 20187:00 amRNSHolding(s) in Company
15th Jan 20187:00 amRNSResult of Tender Offer
11th Jan 20181:08 pmRNSTR-1
9th Jan 20185:01 pmRNSTR-1
5th Jan 20187:00 amRNSResult of Tender Offer
28th Dec 20177:00 amRNSResult of Special Meeting
4th Dec 20177:00 amRNSTender Offer to Shareholders and Notice of Meeting
12th Sep 20177:00 amRNSInterim Results for Six Months Ended 30 June 2017
24th Aug 20177:00 amRNSCOMPANY UPDATE AND DATE OF INTERIM RESULTS
4th Jul 20172:29 pmRNSJoint Development and License Agreement
29th Jun 20177:00 amRNSResult of AGM
7th Jun 20177:00 amRNSTYR TR-1: Notification of major interest in shares
9th May 20177:00 amRNSResults for the Year Ended 31 December 2016
28th Apr 20173:24 pmRNSFurther re Notice of Final Results
22nd Mar 20178:57 amRNSTR-1: Notification of major interest in shares
9th Feb 20177:00 amRNSPre-close Trading Update
19th Sep 20163:59 pmRNSDirector/PDMR Shareholding
15th Sep 20161:18 pmRNSDirectors' Dealings
13th Sep 20167:00 amRNSInterim Results for Six Months Ended 30 June 2016
28th Jul 20167:00 amRNSPre Close Trading Update
8th Jun 20163:22 pmRNSResult of AGM and Board Change
22nd Apr 20161:57 pmRNSDirectors' Dealings
15th Apr 201612:03 pmRNSAward of Share Options
15th Apr 201611:57 amRNSDirectors' Dealings
14th Apr 20167:00 amRNSDirectors' Dealings
11th Apr 20167:00 amRNSAppointment of José Barella as Chairman
4th Apr 20167:00 amRNSNotice of Preliminary Results
3rd Feb 201612:31 pmRNSHolding(s) in Company
1st Feb 20161:08 pmRNSDirector's Dealings
1st Feb 20167:00 amRNSPre-close Trading Update
20th Jan 20167:00 amRNSAppointment of Erica H. Boisvert as CFO
13th Jan 20167:00 amRNSNew Product Range Launch & Distribution Agreement
17th Dec 20154:01 pmRNSTR-1: Notification of Major Interest in Shares
4th Dec 201511:00 amRNSTR-1: Notification of major interest in shares
26th Nov 201512:51 pmRNSTR-1: Notification of Major Interest in Shares
16th Nov 20155:01 pmRNSResult of Special Meeting & Director Shareholdings
4th Nov 20157:00 amRNSPlacing and Subscription to raise £3.16m

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.